New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
07:41 EDTRDUSRadius Health reports Q2 EPS ($2.22), may not compare to consensus (89c)
The net loss per share calculation for the three months ended June 30 includes the weighted average impact of Radius' convertible preferred stock converting into common stock upon the completion of its initial public offering in June. The decrease in net loss for the 2014 period was primarily due to a decrease in research and development expenses.
News For RDUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
09:42 EDTRDUSBarclays biotech analysts hold an analyst/industry conference call
Biotech Analyst Research Team, along with Dr. Felicia Cosman, an osteoporosis specialist and endocrinologist at the Helen Hayes Hospital in New York and Professor of Medicine at Columbia University College of Physicians and Surgeons, discuss Radius Health's Abaloparatide Phase 3 results and market opportunity on an Analyst/Industry conference call to be held on June 29 at 2:30 pm.
June 22, 2015
10:00 EDTRDUSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:26 EDTRDUSRadius Health downgraded to Hold from Buy at Maxim
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use